Successful HeartMate 3 LVAD implantation in a patient with active heparin-induced thrombocytopaenia with thrombosis using pre-implantation plasmapheresis and intraoperative continuous prostacyclin.

Successful HeartMate 3 LVAD implantation in a patient with active heparin-induced thrombocytopaenia with thrombosis using pre-implantation plasmapheresis and intraoperative continuous prostacyclin. - 2021

Heparin-induced thrombocytopaenia describes a prothrombotic state with significant rates of thrombus formation. We present a rare case of successful implantation of a HeartMate 3 left ventricular assist device in a patient with active heparin-induced thrombocytopaenia with thrombosis using preoperative plasmapheresis followed by intraoperative prostacyclin administration. Copyright (c) The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.


English

1569-9285

10.1093/icvts/ivab039 [doi] 6133741 [pii]


*Heart Failure
*Heart-Assist Devices
*Thrombocytopenia
*Thrombosis
Anticoagulants/ae [Adverse Effects]
Epoprostenol
Heart Failure/th [Therapy]
Heparin/ae [Adverse Effects]
Humans
Plasmapheresis
Thrombocytopenia/ci [Chemically Induced]
Thrombocytopenia/th [Therapy]
Thrombosis/ci [Chemically Induced]
Thrombosis/dg [Diagnostic Imaging]


MedStar Heart & Vascular Institute


Journal Article

Powered by Koha